Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H)

被引：0
|
作者：
Berton-Rigaud, D. [1 ,2 ]
Pautier, P. [3 ,4 ]
Lorusso, D. [5 ,6 ]
Gennigens, C. [7 ]
Gladieff, L. [8 ,9 ]
Kryzhanivska, A. [10 ]
Bowman, J. [11 ]
Tian, C. [12 ]
Cornfeld, M.
Van Gorp, T. [13 ]
机构：
[1] GINECO, Serv Oncol Med, St Herblain, France
[2] Inst Cancerol IOuest ICO, St Herblain, France
[3] GINECO, Dept Med, Villejuif, France
[4] Inst Gustave Roussy, Villejuif, France
[5] Fdn Policlin Univ Agostino Gemelli, Gynecol Oncol Unit, Rome, Italy
[6] Univ Cattolica Sacro Cuore, Rome, Italy
[7] Ctr Hosp Univ Sart Tilman, Oncol Gynecol Unit, Liege, Belgium
[8] GINECO, Med Oncol Dept, Toulouse, France
[9] Inst Claudius Regaud IUCT Oncopole, Toulouse, France
[10] Ivano Frankivsk Natl Med Univ, Gynecol Surg Dept, Ivano Frankivsk, Ukraine
[11] Incyte Corp, Immuno Oncol, Wilmington, DE USA
[12] Incyte Corp, Biostat, Wilmington, DE USA
[13] Univ Hosp Leuven, Leuven Canc Inst, Dept Gynaecol, Div Gynaecol Oncol, Leuven, Belgium
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1934
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
755P
引用
收藏
页码：S517 / S517
页数：1
相关论文
共 50 条
  • [41] Real-world data on dostarlimab in post-platinum mismatch repair deficient (dMMR)/ microsatellite instability high (MSI-H) advanced/recurrent (A/R) endometrial cancer: Descriptive analysis of the French cohort temporary authorization of use (ATU)
    Rodrigues, M. J.
    Eberst, L.
    Follana, P.
    Brunel, V.
    Gauthier, L.
    Jacquemin, V. J.
    Tessier, C.
    El Mouaddin, N.
    Boudier, P.
    Fiteni, F.
    Angeli, E.
    Roche, S.
    Bonnet, I.
    Deldycke, C.
    Delanoy, N.
    Sabatier, R.
    Flippot, R.
    Rouge, T. De la Motte
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S801 - S802
  • [42] Efficacy and safety of dostarlimab in UK-specific patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) or DNA polymerase epsilon, catalytic subunit (POLε)-mutated solid tumours in the GARNET study
    Samuel, L.
    Miller, R.
    Ross, P.
    Arkenau, T.
    Antony, G.
    Veneris, J.
    Rule, J.
    Starling, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S73 - S74
  • [43] Combination of nivolumab (nivo) 1 ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 Study
    Lonardi, S.
    Andre, T.
    Wong, K. Y. M.
    Morse, M.
    McDermott, R.
    Hill, A.
    Hendlisz, A.
    Lenz, H.
    Leach, J.
    Moss, R. A.
    Cao, Z. A.
    Ledeine, J.
    Kopetz, S.
    Overman, M.
    ANNALS OF ONCOLOGY, 2017, 28 : 3 - 3
  • [44] Genomic landscapes to characterize mismatch-repair deficiency (dMMR)/microsatellite instability-high (MSI-H) gastrointestinal (GI) cancers stratified by tumor mutation burden (TMB)
    Wang, Jingyuan
    Xiu, Joanne
    Farrell, Alex Patrick
    Battaglin, Francesca
    Arai, Hiroyuki
    Millstein, Joshua
    Soni, Shivani
    Zhang, Wu
    Shields, Anthony F.
    Grothey, Axel
    Weinberg, Benjamin Adam
    Marshall, John
    Lou, Emil
    Khushman, Moh'd M.
    Sohal, Davendra
    Hall, Michael J.
    Oberley, Matthew James
    Spetzler, David
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Updated analysis from a phase 2 study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable/metastatic microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) solid tumors
    Li, Jian
    Xu, Ye
    Zang, Aimin
    Gao, Yunong
    Gao, Quanli
    Zhang, Yanqiao
    Wang, Dong
    Xu, Jianming
    Yuan, Ying
    Jiang, Haiping
    Ying, Jieer
    Shi, Chunmei
    Deng, Yanhong
    Wang, Jing
    Liu, Tianshu
    Huang, Yi
    Xu, Yaling
    Wang, Yidi
    Fei, Cong
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [46] Mismatch repair (MMR) protein expression and next-generation sequencing (NGS) result in microsatellite instability-high (MSI-H) colorectal cancer
    Park, J. H.
    Han, H. S.
    VIRCHOWS ARCHIV, 2020, 477 : S193 - S193
  • [47] A phase 3 study of nivolumab (NIVO), NIVO plus ipilimumab (IPI), or chemotherapy for microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): CheckMate 8HW
    Andre, T.
    Van Cutsem, E.
    Elez, E.
    Bennouna, J.
    de la Fouchardiere, C.
    Yoshino, T.
    Jensen, L.
    Mendez, G.
    Li, J.
    Goekkurt, E.
    Abdullaev, S.
    Chen, T.
    Lei, M.
    Lonardi, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S250 - S250
  • [48] Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC).
    Wong, Alexandra
    Gandhi, Nishant
    Xiu, Joanne
    Algaze, Sandra
    Jayachandran, Priya
    Ashouri, Karam
    Soni, Shivani
    Zhang, Wu
    Lo, Jae Ho
    Mittal, Pooja
    Torres-Gonzalez, Lesly
    Weinberg, Benjamin Adam
    Lou, Emil
    Goel, Sanjay
    Yu, Jian
    Zhang, Lin
    Battaglin, Francesca
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 190 - 190
  • [49] Nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Five-year follow-up from CheckMate 142.
    Overman, Michael J.
    Lenz, Heinz-Josef
    Andre, Thierry
    Aglietta, Massimo
    Wong, Mark Ka
    Luppi, Gabriele
    Van Cutsem, Eric
    McDermott, Raymond S.
    Hendlisz, Alain
    Cardin, Dana Backlund
    Morse, Michael
    Neyns, Bart
    Hill, Andrew Graham
    Limon, M. Luisa
    Garcia-Alfonso, Pilar
    Krishnamurthy, Anuradha
    Chen, Franklin
    Abdullaev, Sandzhar
    Soleymani, Samira
    Lonardi, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Determination of Eligibility for Pembrolizumab Treatment: Comparison of Mismatch Repair Deficiency (dMMR) by IHC, Microsatellite Instability-High (MSI-H) Status by PCR, and MMR Gene Mutations (MMRmut) by NGS
    Yang, Richard
    Ronaghy, Arash
    Abdulrazzaq, Mustafa
    Feinstein, Galina
    Routbort, Mark
    Kopetz, Scott
    Broaddus, Russell
    Prieto, Victor
    Medeiros, L. Jeffrey
    Luthra, Rajyalakshmi
    Patel, Keyur
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 838 - 839
12345